SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Analysts and calls -- SG Cowen

No earlier versions found for this Subject.


Return to Analysts and calls -- SG Cowen
 
2002-10-10
Genentech downgraded at SG Cowen (DNA) 31.88: SG Cowen downgrades to MKT PERFORM from Outperform due to a lack of significant catalysts until mid-2003; says total product sales continue to decelerate, and with a dearth of near-term new product launches, an aging Rituxan will continue to be the sole driver of product sales growthfor the next 12-18 months.

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News